Furthermore, immunohistochemical staining confirmed that atovaquone could promote the protein expression of E-cadherin in lung metastatic carcinoma tissues while inhibiting the expression of N-cadherin and vimentin (Fig. 2-C, D, E). The gene discussed is CDH2; the disease is metastatic carcinoma.